Clinic
Baptist Health
Baptist Health was paid $4.82M by Medicaid between Jan 2018 and Dec 2024, across 176 billing codes. Its largest line is 80053, Comprehensive metabolic panel — 14% of everything it billed.
33Billing provider infoBAPTIST HEALTH
ARKADELPHIA, AR 71923
ARKADELPHIA, AR 71923
33aNPI1174553796assigned 07/03/2006
33bProvider typeRehabilitation Clinic/Center
28Total paid$4.82M
24GClaims251,946
24DCodes billed176
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Rehabilitation Clinic/Center providers in Arkansas
Rank by total paid#12 of 27
Median peer was paid$3.03M
This provider vs. median1.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official WELLS, TROY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 35,127 | $537K | |
| 2019 | 44,770 | $602K | |
| 2020 | 34,287 | $624K | |
| 2021 | 38,579 | $790K | |
| 2022 | 41,841 | $944K | |
| 2023 | 34,529 | $818K | |
| 2024incomplete | 22,813 | $509K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 80053 | Comprehensive metabolic panel | 14% | 14,805 | 12,026 | $670K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 9.0% | 4,195 | 3,841 | $434K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 8.7% | 3,237 | 2,985 | $420K |
| 70450 | Computed tomography, head or brain; without contrast material | 7.7% | 2,518 | 2,172 | $370K |
| 80048 | Basic metabolic panel (calcium, ionized) | 6.1% | 9,155 | 7,004 | $296K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 5.7% | 7,298 | 1,830 | $274K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 4.5% | 1,563 | 1,344 | $218K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.7% | 18,776 | 14,847 | $129K |
| 36415 | Collection of venous blood by venipuncture | 1.8% | 14,218 | 11,176 | $88K |
| 80050 | General health panel | 1.7% | 1,841 | 1,749 | $83K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.6% | 1,937 | 1,604 | $79K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.5% | 3,983 | 3,195 | $74K |
164 more codes
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.5% | 824 | $71K |
| 80061 | Lipid panel | 1.2% | 4,470 | $56K |
| 71046 | Radiologic examination, chest; 2 views | 1.1% | 3,146 | $53K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 1.1% | 1,141 | $51K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,777 | $47K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 3,962 | $46K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 974 | $46K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 972 | $46K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,476 | $44K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 4,137 | $42K |
| 85027 | <1% | 6,827 | $39K | |
| 87088 | <1% | 4,863 | $39K | |
| 81025 | <1% | 4,177 | $37K | |
| 71045 | Radiologic examination, chest; single view | <1% | 4,984 | $36K |
| 84484 | <1% | 4,585 | $34K | |
| 86901 | <1% | 1,141 | $33K | |
| 80305 | <1% | 2,298 | $32K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 3,112 | $29K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 3,765 | $29K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 913 | $29K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,058 | $28K |
| 80076 | <1% | 1,095 | $28K | |
| 83880 | <1% | 1,563 | $27K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 514 | $25K |
| 73560 | <1% | 767 | $25K | |
| 82550 | <1% | 3,789 | $25K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 3,003 | $25K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 627 | $22K |
| 81001 | <1% | 6,979 | $22K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 526 | $21K |
| 87040 | <1% | 2,542 | $20K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 207 | $20K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 6,757 | $20K |
| 87070 | <1% | 1,731 | $20K | |
| 83690 | <1% | 2,814 | $20K | |
| 83605 | <1% | 2,042 | $19K | |
| 87077 | <1% | 2,246 | $18K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 162 | $18K |
| 86900 | <1% | 1,142 | $17K | |
| 99283 | Emergency room visit (moderate) | <1% | 1,264 | $16K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 85 | $16K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,672 | $15K |
| 97162 | <1% | 150 | $13K | |
| 80306 | <1% | 697 | $13K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,169 | $13K |
| 81003 | <1% | 6,289 | $13K | |
| 72100 | <1% | 379 | $12K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 62 | $12K |
| 82077 | <1% | 620 | $11K | |
| 73630 | <1% | 301 | $10K | |
| 74018 | <1% | 537 | $10K | |
| T1015 | A visit at a community health center or clinic (one all-in rate) | <1% | 874 | $10K |
| 87186 | <1% | 1,964 | $10K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,812 | $9K |
| 86803 | <1% | 424 | $8K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 175 | $8K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 237 | $8K |
| 86780 | <1% | 420 | $8K | |
| 83735 | <1% | 1,573 | $8K | |
| 82150 | <1% | 1,197 | $8K | |
| 73610 | <1% | 379 | $8K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,281 | $7K |
| 82803 | <1% | 366 | $7K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 27 | $7K |
| 80320 | <1% | 404 | $6K | |
| 82607 | <1% | 408 | $6K | |
| 85007 | <1% | 2,071 | $6K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,649 | $6K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,122 | $6K |
| 71020 | <1% | 513 | $6K | |
| 99284 | Emergency room visit (serious) | <1% | 1,584 | $6K |
| 82962 | <1% | 1,141 | $5K | |
| 85610 | <1% | 1,981 | $5K | |
| 96376 | <1% | 282 | $5K | |
| 76830 | Ultrasound, transvaginal | <1% | 74 | $5K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 96 | $5K |
| 82375 | <1% | 376 | $5K | |
| 87340 | <1% | 336 | $5K | |
| 86850 | <1% | 975 | $5K | |
| 82947 | <1% | 1,046 | $5K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 21 | $5K |
| 87631 | <1% | 64 | $4K | |
| 73030 | <1% | 170 | $4K | |
| 85379 | <1% | 520 | $4K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 993 | $4K |
| 87807 | <1% | 349 | $4K | |
| 77080 | <1% | 80 | $4K | |
| 86762 | <1% | 179 | $4K | |
| 80179 | <1% | 185 | $4K | |
| 80329 | <1% | 214 | $3K | |
| 80143 | <1% | 159 | $3K | |
| 97001 | <1% | 96 | $2K | |
| 73130 | <1% | 78 | $2K | |
| 82805 | <1% | 93 | $2K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 179 | $2K |
| 85730 | <1% | 485 | $2K | |
| 87081 | <1% | 195 | $2K | |
| 84436 | <1% | 209 | $2K | |
| 87205 | <1% | 312 | $1K | |
| 86592 | <1% | 269 | $1K | |
| 99285 | Emergency room visit (most serious) | <1% | 27 | $1K |
| 71010 | <1% | 215 | $1K | |
| 73502 | <1% | 49 | $1K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 18 | $1K |
| 74000 | <1% | 86 | $1K | |
| 0353U | <1% | 494 | $919.89 | |
| 82677 | <1% | 27 | $863.50 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 89 | $803.41 |
| 73110 | <1% | 27 | $791.96 | |
| 82570 | <1% | 165 | $756.96 | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 60 | $708.08 |
| 72040 | <1% | 33 | $691.92 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 903 | $659.34 |
| 82105 | <1% | 27 | $598.75 | |
| 82728 | <1% | 46 | $588.58 | |
| 85055 | <1% | 42 | $573.04 | |
| 86336 | <1% | 27 | $544.25 | |
| 82248 | <1% | 87 | $528.40 | |
| 84702 | <1% | 51 | $519.30 | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 16 | $512.07 |
| 82247 | <1% | 78 | $473.22 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 2,093 | $411.02 |
| 84703 | <1% | 46 | $367.91 | |
| 97032 | <1% | 91 | $326.82 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 180 | $322.32 |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | <1% | 412 | $314.46 |
| 74022 | <1% | 13 | $256.00 | |
| J2704 | Injection, propofol, 10 mg | <1% | 309 | $235.35 |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 14 | $227.62 |
| 84550 | <1% | 54 | $215.70 | |
| 80349 | <1% | 15 | $213.50 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 529 | $207.89 |
| 82043 | <1% | 39 | $185.40 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 2,000 | $168.59 |
| 85652 | <1% | 56 | $153.70 | |
| 81002 | <1% | 85 | $146.40 | |
| 83540 | <1% | 28 | $144.79 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 56 | $140.05 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,272 | $137.13 |
| 80164 | <1% | 14 | $119.65 | |
| 81015 | <1% | 120 | $113.68 | |
| 84439 | <1% | 15 | $106.52 | |
| 82950 | <1% | 12 | $90.85 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 118 | $80.68 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 205 | $78.01 |
| 36600 | <1% | 424 | $71.60 | |
| 84450 | <1% | 12 | $66.42 | |
| A9270 | Non-covered item or service | <1% | 2,760 | $53.75 |
| 84100 | <1% | 16 | $40.68 | |
| 90686 | <1% | 21 | $36.64 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 18 | $29.83 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 3,177 | $28.83 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 32 | $20.18 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 76 | $9.03 |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 30 | $5.44 |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 64 | $4.13 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | <1% | 275 | $0.98 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 0% | 110 | $0.00 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 0% | 2,965 | $0.00 |
| G0378 | Hospital observation service, per hour | 0% | 29 | $0.00 |
| J1815 | Injection, insulin, per 5 units | 0% | 49 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 18 | $0.00 |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 0% | 12 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 19 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWELLS, TROY (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Baptist Health Regional Hospitals | Fort Smith, AR | $17.49M |
| Baptist Health | Little Rock, AR | $16.48M |
| Baptist Health | North Little Rock, AR | $14.02M |
| Conway Community Services | Conway, AR | $4.12M |
| Baptist Health | Heber Springs, AR | $3.69M |
| Baptist Health Hospitals | Stuttgart, AR | $2.97M |
| Baptist Health | Little Rock, AR | $2.93M |
| Baptist Health | Malvern, AR | $2.68M |
| Baptist Health Regional Hospitals | Van Buren, AR | $2.46M |
| Baptist Health | Little Rock, AR | $1.83M |
| Baptist Health | Arkadelphia, AR | $1.51M |
| Baptist Health Hospitals | Stuttgart, AR | $901K |
| Baptist Health | Little Rock, AR | $780K |
| Baptist Health | North Little Rock, AR | $411K |
| Baptist Health | Monticello, AR | $367K |
| Baptist Health | Conway, AR | $142K |
| Baptist Health | Little Rock, AR | $88K |
| Baptist Health | Prescott, AR | $33K |
| Baptist Health | Malvern, AR | $31K |
| Baptist Health | Heber Springs, AR | $22K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.